Controversies, Consensus, and Collaboration in the Use of 131I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association | Zendy

R. Michael Tuttle | Zendy; Sukhjeet Ahuja | Zendy; Anca M. Avram | Zendy; Victor Bernet | Zendy; P. Bourguet | Zendy; Gilbert H. Daniels | Zendy; Gary Dillehay | Zendy; Ciprian Draganescu | Zendy; Glenn Flux | Zendy; Dagmar Führer | Zendy; Luca Giovanella | Zendy; Bennett S. Greenspan | Zendy; Markus Luster | Zendy; Kristoff Muylle | Zendy; Johannes W. A. Smit | Zendy; Douglas Van Nostrand | Zendy; Frederik A. Verburg | Zendy; László Hegedűs | Zendy

Open Access

Controversies, Consensus, and Collaboration in the Use of ¹³¹I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association

Author(s) -

R. Michael Tuttle,

Sukhjeet Ahuja,

Anca M. Avram,

Victor Bernet,

P. Bourguet,

Gilbert H. Daniels,

Gary Dillehay,

Ciprian Draganescu,

Glenn Flux,

Dagmar Führer,

Luca Giovanella,

Bennett S. Greenspan,

Markus Luster,

Kristoff Muylle,

Johannes W. A. Smit,

Douglas Van Nostrand,

Frederik A. Verburg,

László Hegedűs

Publication year - 2019

Publication title -

thyroid

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.918

H-Index - 142

eISSN - 1557-9077

pISSN - 1050-7256

DOI - 10.1089/thy.2018.0597

Subject(s) - thyroid cancer , medicine , family medicine , thyroid

Publication of the 2015 American Thyroid Association (ATA) management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer was met with disagreement by the extended nuclear medicine community with regard to some of the recommendations related to the diagnostic and therapeutic use of radioiodine ( 131 I). Because of these concerns, the European Association of Nuclear Medicine and the Society of Nuclear Medicine and Molecular Imaging declined to endorse the ATA guidelines. As a result of these differences in opinion, patients and clinicians risk receiving conflicting advice with regard to several key thyroid cancer management issues.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research